Rufus Pamela, Mohamed Norazlina, Shuid Ahmad Nazrun
Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.
Curr Drug Targets. 2013 Dec;14(14):1689-93. doi: 10.2174/1389450114666131220160357.
Osteoporosis is a metabolic bone disorder that affects both men and women worldwide. It causes low bone mass and therefore increases bone susceptibility to fracture when bone undergoes a minor trauma. Lack of estrogen is the principal cause of osteoporosis. Estrogen, calcium, calcitonin, vitamin D and several antioxidants help in the prevention of osteoporosis. In order to effectively treat osteoporosis, there has been an extended research on the biological activities of traditional medicines since synthetic medicines possess several side effects that reduce their efficacy. Therefore, there is a need to develop new treatment alternatives for osteoporosis. This review centres on the scientific researches carried out on the evaluation of Chinese traditional medicines in the treatment of osteoporosis. Various plants like Achyranthes bidentata, Davallia formosana, polygonatum sibiricum, Cibotium barometz, Er-Zhi-Wan, Curculigo orchioides and a combined treatment of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) with alendronate proved active in preventing post-menopausal osteoporosis.
骨质疏松症是一种代谢性骨病,全球范围内的男性和女性都会受到影响。它会导致骨量降低,因此当骨骼受到轻微创伤时,会增加骨折的易感性。雌激素缺乏是骨质疏松症的主要原因。雌激素、钙、降钙素、维生素D和几种抗氧化剂有助于预防骨质疏松症。由于合成药物具有多种副作用,会降低其疗效,因此为了有效治疗骨质疏松症,人们对传统药物的生物活性进行了广泛研究。因此,需要开发治疗骨质疏松症的新替代疗法。这篇综述聚焦于对中药治疗骨质疏松症的评估所开展的科学研究。牛膝、台湾骨碎补、黄精、金毛狗脊、二至丸、仙茅以及八味地黄丸与阿仑膦酸钠联合治疗已被证明在预防绝经后骨质疏松症方面具有活性。